Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.71
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.50
Today|||52-Week Range
10.90
-67.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-2.8M-1.6M-2.2M-1.9M
 
 
 
 
 
Depreciation24.0K9.0K8.0K8.0K
 
 
 
 
 
Total Other Cash Flow156.0K69.0K66.0K65.0K
 
 
 
 
 
Funds From Operations-2.7M-1.5M-2.1M-1.8M
 
 
 
 
 
Funds From/For Other Operating Expenses284.0K2.3M-1.9M-535.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-2.9M-3.8M-201.0K-1.2M
 
 
 
 
 
 
InvestingCapital Expenditures-3.0K-2.0K0.00-9.0K
 
 
 
 
Fixed Asset Disposal12.0K------
 
 
Net Cash Flow Investing9.0K-2.0K0.00-9.0K
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.6M86.0K977.0K13.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total-50.0K-50.0K-51.0K-50.0K
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing1.5M36.0K926.0K13.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-78.0K-15.0K137.0K54.0K
 
 
 
 
 
 
Net Change In Cash-1.4M-3.8M725.0K12.4M